Premium
Midcycle pericoital intravaginal bee honey and royal jelly for male factor infertility
Author(s) -
Abdelhafiz Ahmed T.,
Muhamad Jehan A.
Publication year - 2008
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1016/j.ijgo.2007.11.012
Subject(s) - asthenozoospermia , gynecology , infertility , insemination , medicine , royal jelly , pregnancy , artificial insemination , controlled ovarian hyperstimulation , pregnancy rate , male infertility , andrology , sperm , biology , genetics , food science
Objective To evaluate the efficacy of pericoital intravaginal applications of a mixture of Egyptian bee honey and royal jelly (H/RJ) in the midcycle for the treatment of infertility due to asthenozoospermia.Methods Sohag University Hospital and Asyut Gynecology and Infertility Clinic conducted a crossover study of 99 couples affected by asthenozoospermia. One group used midcycle pericoital vaginal applications of H/RJ and the other underwent a standard intrauterine insemination (IUI) procedure, for 3 cycles or until conception occurred for both groups. After a washout period of 2 months, the couples for whom no pregnancy occurred were crossed over.Results A total of 553 cycles were analyzed. There were 23 (8.1%) and 7 (2.6%) pregnancies per cycle, respectively, in the H/RJ and the IUI groups, and the difference was statistically significant ( P < 0.001).Conclusion Using H/RJ intravaginally might be a simple and reasonably effective method of treating asthenozoospermia.